Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.

24.03.2005

In today’s extraordinary shareholder’s meeting the shareholder Ian
Humphrey-Smith informed the audience and LION bioscience AG about a
likely non-binding and non-specific take-over respectively purchase
offer for LION bioscience AG respectively for its assets. Mr.
Humphrey-Smith indicated that he would not act on his own behalf, but
on behalf of a group of investors namely FM Fund Management Ltd. and
Zapis Capital Group.

In case of a binding and specific take-over respectively purchase
offer, LION bioscience AG would review such an offer seriously.

end of announcement                    euro adhoc 24.03.2005 14:01:16 

Further inquiry note:

Günter Dielmann
Vice President Investor Relations
+49 (0) 6221-4038 249

Branche: Biotechnology
ISIN: DE0005043509
WKN: 504350
Index: Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade